22nd July, 2020
The facility will house a state-of-the-art 180 thousand Litre fermentation capability which can produce multiple recombinant biotechnology products for Biopharma, Cell culture and Food industries.
This new facility will help Richcore multiply its manufacturing capability 20 times by January 2021. This new plant is the first of the many large scale global quality Bio-Manufacturing sites Richcore plans to establish in the next few years.
Richcore’s expansion will go a long way in augmenting indigenous manufacturing of biomedical resources and strengthening India’s domestic supply chain, especially important in the backdrop of the Govt’s call for local sourcing and local manufacturing.
The foundation stone for the Tumakuru facility was laid by the Honorable DY CM and IT/ BT Minister, Karnataka Dr C.N Ashwathanaryan on June 15th 2020. While congratulating the Richcore team, he said, that it is “Great to see Karnataka’s BT sector continue expanding beyond the city limits of Bengaluru, into innovative tier two cities” and appreciated Richcore’s “Make in India” Initiative.
Established in 2005 and currently located in Jigani, Bangalore, Richcore’s USP is Non-Animal Origin ‘green’ recombinant protein technology. Their products enable global biologics, vaccine and cell culture companies, achieve higher levels of drug safety compliance by replacing viral-contamination prone, animal-derived components with their recombinant Non-animal Origin (NAO) alternatives. For example, their recombinant trypsin (rcTrypsin) has enabled production of more than 10 billion doses of safer insulin shots till date. Moreover optimized cGMP development & cGMP certified manufacturing platforms enable them to adhere to international quality control and safety standards.
C-CAMP CEO and Director, Dr. Taslimarif Saiyed, also Convener of the NBRIC Governing Council, said “As a national and global supplier of world-class recombinant protein technologies, a critical component of many biotech and biopharma products, this development at Richcore is of immense significance for India’s Aatma Nirbhar Bharat Abhiyan. NBRIC welcomes and congratulates Richcore on this achievement and looks forward to working with all stakeholders towards making India a self-sufficient bio-manufacturing hub.”
Constituted by Department of Biotechnology, Government of India and hosted, convened by C-CAMP, NBRIC is a collaborative Public Private Partnership to drive indigenous innovation focused on developing reagents, diagnostics, vaccines and therapeutics for COVID19 and beyond.
About Richcore: http://www.richcoreindia.com